Medical biometric firm Biotricity reshaping market through pioneering innovation
REDWOOD CITY, Calif., Mar 07, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity reports financial results for Fiscal 2023 Third Quarter
REDWOOD CITY, Calif., Feb 14, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity To host Fiscal 2023 Third Quarter Financial Results call on February 14th at 4:30pm ET
REDWOOD CITY, Calif., Feb 09, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity selected to present its work on AI enabled stroke prediction in CKD patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
REDWOOD CITY, Calif., Feb 03, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity signs distribution agreement with top 5 distributor for its Cardiac Monitoring Solutions
REDWOOD CITY, Calif., Jan 26, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET
REDWOOD CITY, Calif., Jan 23, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity signs with top 5 group purchasing organization; potential for higher sales volume in 2023
REDWOOD CITY, Calif., Jan 17, 2023 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth
REDWOOD CITY, Calif., Dec 12, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity surpasses $10 million in annual revenue run rate
REDWOOD CITY, Calif., Nov 21, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity provides updates on its operational and expansion strategy
REDWOOD CITY, Calif., Nov 18, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity signs Distribution Agreement to expand access for its Cardiac Monitoring Solutions
REDWOOD CITY, Calif., Nov 16, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity reports financial results for Fiscal 2023 Second Quarter
REDWOOD CITY, Calif., Nov 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity’s Bioheart named to TIME’s list of The Best Inventions of 2022
REDWOOD CITY, Calif., Nov 10, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to host Fiscal 2023 Second Quarter financial results on November 14th at 4:30 PM ET
REDWOOD CITY, Calif., Nov 01, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity launches Cardiac Disease Management Solution following 2 successful pilots with Oklahoma & Kentucky Clinics
REDWOOD CITY, Calif., Oct 26, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity CEO, Waqaas Al-Siddiq, to participate in panel discussion on the evolution of medical devices at the American Medical Device Summit on October 19th
REDWOOD CITY, Calif., Oct 11, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity surpasses 2 billion recorded and analyzed heartbeats for atrial fibrillation (AFib)
REDWOOD CITY, Calif., Oct 04, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled real-time monitoring and predictive analytics for stroke due to chronic kidney failure
REDWOOD CITY, Calif., Sep 07, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…